394 related articles for article (PubMed ID: 18183033)
1. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
[TBL] [Abstract][Full Text] [Related]
2. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
3. How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.
Perles-Barbacaru AT; van der Sanden BP; Farion R; Lahrech H
J Cereb Blood Flow Metab; 2012 Mar; 32(3):489-501. PubMed ID: 22068227
[TBL] [Abstract][Full Text] [Related]
4. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
Hirschberg H; Wu GN; Madsen SJ
Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of a new bioactivated paramagnetic gadolinium(III) complex [Gd(DOTA-FPG)(H2O)] for tracing gene expression.
Chang YT; Cheng CM; Su YZ; Lee WT; Hsu JS; Liu GC; Cheng TL; Wang YM
Bioconjug Chem; 2007; 18(6):1716-27. PubMed ID: 17935289
[TBL] [Abstract][Full Text] [Related]
7. [Blood volume changes after the radiotherapy of the central nervous system].
Wenz F; Fuss M; Scholdei R; Essig M; Lohr F; Rempp K; Brix G; Knopp MV; Engenhart R; Wannenmacher M
Strahlenther Onkol; 1996 Oct; 172(10):559-66. PubMed ID: 8966673
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. In vivo quantification using magnetic resonance imaging and Gd-DTPA.
Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
Acta Radiol; 1990 Mar; 31(2):203-8. PubMed ID: 2372465
[TBL] [Abstract][Full Text] [Related]
10. Partial-volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas.
Lee MC; Cha S; Chang SM; Nelson SJ
J Magn Reson Imaging; 2006 Mar; 23(3):257-66. PubMed ID: 16456821
[TBL] [Abstract][Full Text] [Related]
11. [The effect of Gd-DTPA on magnetic resonance imaging: a potential blood-brain barrier indicator].
Hashimoto K; Yamagata S; Minamikawa J; Watanabe Y; Kanesiro M; Kikuchi H
No To Shinkei; 1988 May; 40(5):461-6. PubMed ID: 3415864
[TBL] [Abstract][Full Text] [Related]
12. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
[TBL] [Abstract][Full Text] [Related]
14. Gd-DISIDA--a potential contrast agent for magnetic resonance imaging of the hepatobiliary system.
Saha GB; Bateson BP; Meaney TF; Ng TC; Go RT; MacIntyre WJ; Feiglin DH; O'Donnell JK
J Nucl Med Allied Sci; 1989; 33(1):1-6. PubMed ID: 2746364
[TBL] [Abstract][Full Text] [Related]
15. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach.
Wirestam R; Knutsson L; Risberg J; Börjesson S; Larsson EM; Gustafson L; Passant U; Ståhlberg F
Acta Radiol; 2007 Jun; 48(5):550-6. PubMed ID: 17520432
[TBL] [Abstract][Full Text] [Related]
16. Investigation of sandwiched gadolinium (III) complexes with tungstosilicates as potential MRI contrast agents.
Sun G; Feng J; Wu H; Pei F; Fang K; Lei H
Magn Reson Imaging; 2004 Apr; 22(3):421-6. PubMed ID: 15062939
[TBL] [Abstract][Full Text] [Related]
17. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility.
Aronen HJ; Glass J; Pardo FS; Belliveau JW; Gruber ML; Buchbinder BR; Gazit IE; Linggood RM; Fischman AJ; Rosen BR
Acta Radiol; 1995 Sep; 36(5):520-8. PubMed ID: 7640098
[TBL] [Abstract][Full Text] [Related]
18. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
[TBL] [Abstract][Full Text] [Related]
20. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI.
Newman GC; Hospod FE; Patlak CS; Fain SE; Pulfer KA; Cook TD; O'Sullivan F
J Cereb Blood Flow Metab; 2006 Jun; 26(6):760-70. PubMed ID: 16319833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
